Skip to content

A CLINICAL TRIAL TO STUDY THE EFFECT OF TWO DRUGS, FERRIC-CARBOXY MALTOSE AND IRON SUCROSE COMPLEX FOR TREATMENT OF IRON DEFICIENCY ANEMIA IN PREGNANT WOMEN

COMPARISON OF IRON SUCROSE COMPLEX AND FERRIC CARBOXYMALTOSE FOR TREATMENT OF IRON DEFICIENCY ANEMIA IN ANTE-PARTUM PATIENTS: A RANDOMIZED CONTROL TRIAL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049803
Enrollment
220
Registered
2023-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O990- Anemia complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: intravenous,iron,prepration: Ante-partum,patients,having,iron,deficiency,anemia,will,be,treated,with,injectable,iron,theraphy,accoding,to,total,iron,deficiency,calculated,based,on,gazon

Sponsors

BPS Govt. Medical College for Women, Khanpur kalan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Ante-partum women Age between 18 to 35 years. Hemoglobin between 6-9.9 gm %.. Iron deficiency anemia 24-34 weeks of period of gestation

Exclusion criteria

Exclusion criteria: Other than Iron Deficiency Anemia Acute or Chronic Liver diseases HIV 1st Trimester of Pregnancy Serum transaminases > 1.5 times upper limit of normal Serum Creatinine > 2.0 mg/dL History of allergic reaction to intravenous iron infusion Anemia due to other causes Thalassemia patient Iron metabolic disorder Hemosiderosis Hemochromatosis Untreated Pyelonephritis Anaphylactic Reaction

Design outcomes

Primary

MeasureTime frame
Change in Hb level from baseline on follow-up visitsTimepoint: baseline, 3 weeks, 6 weeks, 9 weeks

Secondary

MeasureTime frame
Change in RBC indices, RDW, change in serum ferritin levels,change in fatigue levels, safety and side effects of treatment and peri-natal outcome (in terms of time of delivery/ abortion/preterm delivery)Timepoint: baseline, 3 weeks, 6 weeks, 9 weeks

Countries

India

Contacts

Public ContactDr Ankit Kumar Dangi

Bhagat Phool Singh Govt. Medical College for Women, Khanpur kalan, Sonepat

siwachsunita@ymail.com9812266400

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026